The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Hill-Vinson, who taught Brown in her Introduction to Multimedia Writing class at Ole Miss, says he was "one of those students ...